Exploring the Purpose and Impact of the Ponesimod Point Study on Medical Research
The Ponesimod Point Study delves into the potential of ponesimod as an add-on therapy for patients with active relapsing multiple sclerosis who do not respond adequately to dimethyl fumarate. Despite facing recruitment challenges, the study offers insights into disease activity reduction and safety, highlighting the need for further research in MS treatment strategies. Understanding the […]
3 minute read